Complete Filing Data
Vor Biopharma Inc. reported Stockholders Equity of -$164.31 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Vor Biopharma Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$696.0M | -$116.9M | -$117.9M | -$92.1M | -$68.9M | -$43.3M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $19.0K | $99.0K | $693.0K | -$770.0K | ||
| Research And Development Expense | $321.5M | $93.3M | $94.3M | $64.6M | $47.5M | $31.6M |
| Operating Income Loss | -$371.6M | -$121.2M | -$126.0M | -$93.4M | -$69.0M | -$43.4M |
| Operating Expenses | $371.6M | $121.2M | $126.0M | $93.4M | $69.0M | $43.4M |
| General And Administrative Expense | $50.1M | $27.9M | $31.7M | $28.9M | $21.5M | $11.7M |
| Nonoperating Income Expense | -$324.3M | $4.3M | $8.2M | $1.3M | $119.0K | $29.0K |
| Comprehensive Income Net Of Tax | -$696.0M | -$116.8M | -$117.2M | -$92.9M | -$70.1M | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $19.0K | $99.0K | $693.0K | -$770.0K | ||
| Net Income Loss Available To Common Stockholders Basic | -$92.1M | -$70.1M | -$49.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$812.7M | -$1.57B | -$32.5M | -$27.6M | -$27.8M | -$30.8M | -$33.2M | -$30.0M | -$28.4M | -$23.8M | -$21.7M | -$22.7M | -$18.6M | -$18.4M | -$13.7M | -$11.8M | -$8.0M | -$7.8M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$2.0K | -$9.0K | $1.0K | $138.0K | $17.0K | -$10.0K | $156.0K | -$262.0K | $596.0K | $148.0K | -$254.0K | -$1.1M | ||||||
| Research And Development Expense | $14.1M | $261.5M | $26.7M | $21.8M | $21.8M | $24.3M | $27.6M | $23.9M | $21.9M | $16.9M | $15.3M | $15.3M | $12.9M | $13.0M | $8.9M | $8.1M | $6.0M | $6.2M |
| Operating Income Loss | -$28.1M | -$274.3M | -$33.3M | -$28.5M | -$29.0M | -$32.3M | -$35.3M | -$32.2M | -$30.4M | -$24.1M | -$21.8M | -$22.8M | -$18.6M | -$18.4M | -$13.7M | -$11.8M | -$8.0M | -$7.9M |
| Operating Expenses | $28.1M | $274.3M | $33.3M | $28.5M | $29.0M | $32.3M | $35.3M | $32.2M | $30.4M | $24.1M | $21.8M | $22.8M | $18.6M | $18.4M | $13.7M | $11.8M | $8.0M | $7.9M |
| General And Administrative Expense | $14.0M | $12.8M | $6.6M | $6.7M | $7.2M | $8.0M | $7.7M | $8.3M | $8.5M | $7.2M | $6.5M | $7.5M | $5.7M | $5.4M | $4.8M | $3.6M | $2.1M | $1.7M |
| Nonoperating Income Expense | -$784.6M | -$1.30B | $805.0K | $954.0K | $1.2M | $1.5M | $2.1M | $2.2M | $2.0M | $313.0K | $133.0K | $63.0K | $48.0K | $10.0K | $7.0K | $29.0K | ||
| Comprehensive Income Net Of Tax | -$812.7M | -$1.57B | -$32.5M | -$27.4M | -$27.8M | -$30.8M | -$33.0M | -$30.2M | -$27.8M | -$23.6M | -$21.9M | -$23.8M | -$18.6M | -$18.4M | -$15.0M | |||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$2.0K | -$9.0K | $1.0K | $138.0K | $17.0K | -$10.0K | $156.0K | -$262.0K | $596.0K | $148.0K | -$254.0K | -$1.1M | ||||||
| Net Income Loss Available To Common Stockholders Basic | -$23.8M | -$21.7M | -$22.7M | -$18.6M | -$18.4M | -$15.0M | -$14.0M | -$8.9M | -$8.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$164.3M | $96.7M | $150.7M | $250.6M | $216.3M | -$59.1M | -$17.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $396.7M | $84.4M | $33.8M | $60.1M | $122.2M | $50.1M | $8.0M |
| Cash And Cash Equivalents At Carrying Value | $396.5M | $81.9M | $31.4M | $57.7M | $119.8M | $48.5M | |
| Restricted Cash Equivalents Noncurrent | $168.0K | $2.4M | $2.4M | $2.4M | $2.4M | $1.6M | |
| Retained Earnings Accumulated Deficit | -$1.15B | -$457.0M | -$340.1M | -$222.2M | -$130.1M | -$61.2M | |
| Property Plant And Equipment Net | $533.0K | $6.6M | $10.1M | $12.6M | $6.9M | $4.7M | |
| Other Assets Noncurrent | $2.4M | $2.4M | $4.8M | $2.9M | $3.3M | $3.4M | |
| Other Assets Current | $1.7M | $380.0K | $475.0K | $2.3M | $2.1M | $100.0K | |
| Operating Lease Right Of Use Asset | $2.9M | $35.0M | $40.0M | $44.4M | $15.7M | $17.1M | |
| Operating Lease Liability Noncurrent | $2.7M | $27.6M | $31.8M | $35.6M | $16.2M | $17.4M | |
| Operating Lease Liability Current | $280.0K | $4.2M | $3.8M | $3.3M | $1.8M | $863.0K | |
| Liabilities Current | $25.2M | $18.6M | $15.6M | $13.1M | $10.2M | $10.2M | |
| Liabilities And Stockholders Equity | $464.1M | $142.9M | $198.1M | $299.4M | $242.6M | $75.9M | |
| Liabilities | $628.4M | $46.2M | $47.4M | $48.8M | $26.3M | $27.6M | |
| Common Stock Value | $18.0K | $13.0K | $7.0K | $7.0K | $4.0K | $1.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $312.3M | $50.6M | -$26.3M | -$62.1M | $72.1M | $42.1M | |
| Assets Current | $458.1M | $96.5M | $140.8M | $237.0M | $214.4M | $49.1M | |
| Assets | $464.1M | $142.9M | $198.1M | $299.4M | $242.6M | $75.9M | |
| Additional Paid In Capital Common Stock | $988.6M | $553.6M | $490.9M | $473.6M | $346.4M | $2.2M | |
| Accrued Liabilities Current | $19.8M | $12.9M | $10.9M | $7.9M | $6.3M | $6.3M | |
| Accounts Payable Current | $5.1M | $1.5M | $815.0K | $1.8M | $1.5M | $2.4M | |
| Operating Lease Expense | $5.6M | $5.0M | $4.7M | $3.6M | $3.0M | $782.0K | |
| Other Liabilities Current | $50.0K | $186.0K | $434.0K | $723.0K | |||
| Marketable Securities Current | $58.7M | $10.0M | $105.8M | $172.5M | $87.7M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $41.0K | $22.0K | -$77.0K | -$770.0K | |||
| Interest Amortization On Marketable Securities | $67.0K | $1.1M | $4.7M | $12.0K | |||
| Financing Costs Associated With The Sale Of Common Stock Included In Accounts Payable And Accrued Expenses | $127.0K | $563.0K | $27.0K | $812.0K | |||
| Stock Issued During Period Value Issuance Of Common Stock From Open Market Sales Agreement | |||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $3.1M | $0.00 | $23.4M | ||||
| Redeemable Preferred Stock Dividends | $1.2M | $5.9M | |||||
| Operating Right Of Use Assets And Operating Lease Liability Recorded Upon Lease Commencement | $23.4M | $35.0K | $17.9M | ||||
| Stock Issued During Period Value Issuance Of Common Stock From At The Market Sales Agreement | $70.1M | $302.0K | $4.7M | $4.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$2.23B | -$1.51B | $66.1M | $73.0M | $98.1M | $123.0M | $174.8M | $204.5M | $230.2M | $158.7M | $175.0M | $194.4M | $233.0M | $250.1M | $267.2M | -$44.1M | -$33.0M | -$25.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $160.6M | $193.0M | $52.5M | $55.2M | $78.5M | $47.4M | $47.4M | $34.6M | $44.9M | $63.2M | $65.4M | $92.5M | $145.4M | $171.1M | $264.1M | $65.2M | $74.5M | $19.2M | |
| Cash And Cash Equivalents At Carrying Value | $160.5M | $190.6M | $50.0M | $52.8M | $76.1M | $45.0M | $45.0M | $32.2M | $42.5M | $60.8M | $63.0M | $90.0M | $143.0M | $169.5M | $262.6M | $63.6M | $72.9M | ||
| Restricted Cash Equivalents Noncurrent | $168.0K | $0.00 | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $1.6M | $1.6M | $1.6M | $1.6M | ||
| Retained Earnings Accumulated Deficit | -$2.88B | -$2.06B | -$489.5M | -$426.3M | -$398.7M | -$370.9M | -$313.8M | -$280.6M | -$250.7M | -$198.3M | -$174.5M | -$152.9M | -$111.9M | -$93.3M | -$74.9M | ||||
| Property Plant And Equipment Net | $271.0K | $0.00 | $6.0M | $7.5M | $8.3M | $9.2M | $10.8M | $11.5M | $11.9M | $13.0M | $14.8M | $11.8M | $6.0M | $5.9M | $5.7M | ||||
| Other Assets Noncurrent | $269.0K | $420.0K | $2.4M | $2.5M | $3.1M | $4.8M | $4.1M | $3.3M | $2.8M | $2.9M | $2.4M | $8.2M | $2.1M | $2.1M | $2.6M | ||||
| Other Assets Current | $1.3M | $449.0K | $297.0K | $285.0K | $272.0K | $507.0K | $667.0K | $539.0K | $459.0K | $1.8M | $2.3M | $2.2M | $749.0K | $65.0K | $92.0K | ||||
| Operating Lease Right Of Use Asset | $3.0M | $24.0K | $33.7M | $36.3M | $37.6M | $38.8M | $41.3M | $42.5M | $43.6M | $45.4M | $46.1M | $21.6M | $16.0M | $16.4M | $16.8M | ||||
| Operating Lease Liability Noncurrent | $2.8M | $0.00 | $26.5M | $28.7M | $29.7M | $30.8M | $32.9M | $33.8M | $34.7M | $36.5M | $37.4M | $21.7M | $16.5M | $16.7M | $17.1M | ||||
| Operating Lease Liability Current | $252.0K | $0.00 | $4.3M | $4.2M | $4.1M | $4.0M | $3.7M | $3.7M | $3.7M | $3.8M | $4.4M | $7.3M | $1.1M | $1.2M | $1.2M | ||||
| Liabilities Current | $18.8M | $58.8M | $16.7M | $14.3M | $13.8M | $13.2M | $15.4M | $12.7M | $12.6M | $11.1M | $12.3M | $18.1M | $9.2M | $8.3M | $8.6M | ||||
| Liabilities And Stockholders Equity | $176.2M | $205.4M | $109.3M | $116.0M | $141.6M | $167.0M | $223.0M | $251.0M | $277.5M | $206.4M | $224.6M | $234.3M | $258.6M | $275.1M | $292.9M | ||||
| Liabilities | $2.40B | $1.71B | $43.2M | $43.0M | $43.5M | $44.0M | $48.2M | $46.5M | $47.3M | $47.6M | $49.6M | $39.8M | $25.7M | $25.0M | $25.8M | ||||
| Common Stock Value | $15.0K | $13.0K | $13.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$31.9M | $13.6M | -$15.3M | -$29.8M | $214.0M | $11.1M | |||||||||||||
| Assets Current | $172.5M | $204.9M | $64.8M | $67.3M | $90.3M | $111.8M | $164.4M | $191.4M | $216.9M | $142.7M | $158.8M | $190.3M | $232.1M | $249.3M | $266.3M | ||||
| Assets | $176.2M | $205.4M | $109.3M | $116.0M | $141.6M | $167.0M | $223.0M | $251.0M | $277.5M | $206.4M | $224.6M | $234.3M | $258.6M | $275.1M | $292.9M | ||||
| Additional Paid In Capital Common Stock | $650.3M | $557.4M | $555.5M | $499.2M | $496.9M | $494.0M | $488.9M | $485.5M | $481.0M | $358.2M | $350.8M | $348.4M | $344.8M | $343.4M | $342.1M | ||||
| Accrued Liabilities Current | $17.7M | $58.1M | $8.7M | $8.9M | $7.7M | $6.8M | $10.3M | $7.3M | $5.5M | $6.3M | $6.3M | $9.3M | $5.7M | $4.3M | $4.4M | ||||
| Accounts Payable Current | $885.0K | $669.0K | $3.7M | $1.3M | $2.0M | $2.3M | $1.3M | $1.6M | $3.2M | $824.0K | $1.3M | $1.3M | $2.0M | $2.4M | $2.4M | ||||
| Operating Lease Expense | $1.3M | $1.2M | $1.1M | $920.0K | $322.0K | ||||||||||||||
| Other Liabilities Current | $44.0K | $0.00 | $13.0K | $25.0K | $134.0K | $62.0K | $122.0K | $165.0K | $233.0K | $279.0K | $351.0K | $430.0K | $478.0K | $675.0K | |||||
| Marketable Securities Current | $10.0M | $10.0M | $10.0M | $10.0M | $9.9M | $62.5M | $115.1M | $154.7M | $167.7M | $75.2M | $88.1M | $91.6M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $12.0K | $14.0K | $23.0K | $68.0K | -$70.0K | -$87.0K | -$280.0K | -$436.0K | -$174.0K | -$1.2M | -$1.3M | -$1.1M | |||||||
| Interest Amortization On Marketable Securities | $11.0K | $797.0K | $1.2M | ||||||||||||||||
| Financing Costs Associated With The Sale Of Common Stock Included In Accounts Payable And Accrued Expenses | $0.00 | $92.0K | |||||||||||||||||
| Stock Issued During Period Value Issuance Of Common Stock From Open Market Sales Agreement | $213.0K | $386.0K | $555.0K | $3.7M | $3.8M | $553.0K | |||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $270.0K | $6.4M | |||||||||||||||||
| Redeemable Preferred Stock Dividends | $1.2M | $2.2M | $855.0K | $715.0K | |||||||||||||||
| Operating Right Of Use Assets And Operating Lease Liability Recorded Upon Lease Commencement | $6.3M | ||||||||||||||||||
| Stock Issued During Period Value Issuance Of Common Stock From At The Market Sales Agreement | $20.3M | $89.0K | $213.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $18.9M | $9.8M | $13.4M | $10.7M | $4.3M | $1.3M |
| Payments To Acquire Property Plant And Equipment | $941.0K | $229.0K | $1.1M | $8.5M | $3.9M | $4.2M |
| Net Cash Provided By Used In Operating Activities | -$142.7M | -$99.7M | -$100.3M | -$85.1M | -$69.1M | -$36.3M |
| Net Cash Provided By Used In Investing Activities | -$48.8M | $96.9M | $71.0M | -$94.1M | -$91.7M | -$4.2M |
| Net Cash Provided By Used In Financing Activities | $503.8M | $53.4M | $2.9M | $117.1M | $232.9M | $82.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.7M | $835.0K | -$3.3M | -$225.0K | $6.4M | -$606.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $10.9M | $2.2M | $2.9M | $1.1M | $405.0K | $5.8M |
| Increase Decrease In Operating Lease Liability | -$2.4M | -$3.8M | -$3.6M | -$10.5M | -$2.6M | $393.0K |
| Increase Decrease In Other Operating Assets | $0.00 | -$2.4M | $1.9M | $721.0K | $668.0K | $2.5M |
| Payments To Acquire Marketable Securities | $53.7M | $9.9M | $74.9M | $123.2M | $87.8M | |
| Proceeds From Sale And Maturity Of Marketable Securities | $5.0M | $107.0M | $147.0M | $37.6M | ||
| Proceeds From Issuance Of Common Stock | $70.1M | $275.0K | $4.6M | $4.5M | ||
| Payments Related To Tax Withholding For Share Based Compensation | $254.0K | $333.0K | $1.2M | |||
| Proceeds From Stock Option Exercises And The Issuance Of Shares Under Espp | 2.2M | 225.0K | 264.0K | 1.2M | ||
| Proceeds From Stock Options Exercised | $553.0K | $259.0K | ||||
| Payments Of Stock Issuance Costs | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $1.9M | $3.1M | $4.1M | $1.7M | $891.0K | $112.0K |
| Payments To Acquire Property Plant And Equipment | $231.0K | $114.0K | $94.0K | $2.0M | $1.2M | $545.0K |
| Net Cash Provided By Used In Operating Activities | -$31.1M | -$30.5M | -$24.3M | -$22.9M | -$17.6M | -$6.1M |
| Net Cash Provided By Used In Investing Activities | -$230.0K | $44.0M | $6.5M | -$7.1M | -$1.2M | -$545.0K |
| Net Cash Provided By Used In Financing Activities | -$606.0K | $96.0K | $2.5M | $200.0K | $232.8M | $17.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $231.0K | $710.0K | -$7.0K | $1.7M | $3.1M | $347.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$1.4M | -$2.5M | -$88.0K | -$722.0K | -$2.4M | $1.9M |
| Increase Decrease In Operating Lease Liability | -$1.0M | -$921.0K | -$730.0K | -$727.0K | -$16.0K | |
| Increase Decrease In Other Operating Assets | -$14.0K | $7.0K | -$134.0K | $135.0K | -$141.0K | |
| Payments To Acquire Marketable Securities | $0.00 | $9.9M | $23.4M | $5.0M | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $1.0K | $54.0M | $30.0M | |||
| Proceeds From Issuance Of Common Stock | $0.00 | $278.0K | $3.6M | |||
| Payments Related To Tax Withholding For Share Based Compensation | $55.0K | $182.0K | $400.0K | |||
| Proceeds From Stock Option Exercises And The Issuance Of Shares Under Espp | ||||||
| Proceeds From Stock Options Exercised | $14.0K | $200.0K | $18.0K | $43.0K | ||
| Payments Of Stock Issuance Costs | $551.0K | $0.00 | $1.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$70.50 | -$34.03 | -$1.75 | -$2.33 | -$2.10 | -$230.57 |
| Weighted Average Number Of Shares Outstanding Basic | 9.9M | 3.4M | 67.2M | 39.6M | 33.4M | |
| Weighted Average Number Of Diluted Shares Outstanding | 9.9M | 3.4M | 67.2M | 39.6M | 33.4M | |
| Earnings Per Share Basic | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 800.0M | 400.0M | 400.0M | 400.0M | 400.0M | 420.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Outstanding | 38.7M | 6.2M | 67.9M | 66.0M | 37.2M | 505.1K |
| Common Stock Shares Issued | 38.7M | 6.2M | 67.9M | 66.1M | 37.4M | 893.2K |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 33.4M | 213.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$121.63 | -$12.56 | -$0.26 | -$8.05 | -$0.41 | -$0.45 | -$0.49 | -$0.45 | -$0.43 | -$0.63 | -$0.58 | -$0.61 | -$0.50 | -$0.50 | -$0.67 | -$61.23 | -$56.85 | -$59.06 |
| Weighted Average Number Of Shares Outstanding Basic | 6.7M | 125.3M | 124.8M | 3.4M | 68.3M | 68.0M | 67.6M | 67.0M | 66.3M | 38.0M | 37.4M | 37.3M | 36.9M | 36.8M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 6.7M | 125.3M | 124.8M | 3.4M | 68.3M | 68.0M | 67.6M | 67.0M | 66.3M | 38.0M | 37.4M | 37.3M | 36.9M | 36.8M | ||||
| Earnings Per Share Basic | $-121.63 | $-12.56 | $-0.26 | $-8.05 | $-0.41 | $-0.45 | $-0.49 | $-0.45 | $-0.43 | $-0.63 | $-0.58 | $-0.61 | $-0.50 | $-0.50 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 800.0M | 800.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Common Stock Shares Outstanding | 9.0M | 125.6M | 124.9M | 68.7M | 68.4M | 68.2M | 67.8M | 67.4M | 66.9M | 38.4M | 37.5M | 37.3M | 37.0M | 36.9M | 36.8M | |||
| Common Stock Shares Issued | 9.0M | 125.6M | 124.9M | 68.7M | 68.4M | 68.2M | 67.8M | 67.5M | 67.0M | 38.5M | 37.6M | 37.5M | 37.2M | 37.1M | 37.1M | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 37.3M | 36.9M | 36.8M | 22.3M | 228.1K | 156.5K | 145.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $18.9M | $9.8M | $13.4M | $10.7M | $4.3M | $1.3M |
| Depreciation | $2.9M | $3.5M | $3.5M | $2.5M | $1.4M | $605.0K |
| Investment Income Interest | $5.9M | $4.3M | $8.2M | $1.3M | $119.0K | $29.0K |
| Prepaid Expense Current | $1.2M | $4.2M | $3.2M | $4.4M | $4.8M | $467.0K |
| Capital Expenditures Incurred But Not Yet Paid | $70.0K | $38.0K | $194.0K | $444.0K | ||
| Stock Issued During Period Value Stock Options Vested And Exercised | $1.2M | $894.0K | ||||
| Stock Issued During Period Value Stock Options Vested Of Restricted Stock Units And Exercised |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $8.0M | $1.8M | $1.9M | $2.3M | $2.8M | $3.1M | $3.2M | $4.2M | $4.1M | $3.3M | $1.7M | $1.7M | $1.2M | $1.1M | $891.0K | $483.0K | $153.0K | $112.0K |
| Depreciation | $2.1M | $825.0K | $900.0K | $900.0K | $943.0K | $900.0K | $900.0K | $837.0K | $900.0K | $600.0K | $426.0K | $300.0K | $400.0K | $311.0K | $200.0K | $100.0K | $66.0K | |
| Investment Income Interest | $1.7M | $537.0K | $805.0K | $954.0K | $1.2M | $1.5M | $2.1M | $2.2M | $2.0M | $313.0K | $133.0K | $63.0K | $48.0K | $10.0K | $7.0K | $29.0K | ||
| Prepaid Expense Current | $747.0K | $1.5M | $4.5M | $4.2M | $4.0M | $3.8M | $3.7M | $4.0M | $6.2M | $4.9M | $5.5M | $6.5M | $5.4M | $4.6M | $3.6M | |||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $14.0K | $3.0K | $3.5M | $149.0K | $270.0K | ||||||||||||
| Stock Issued During Period Value Stock Options Vested And Exercised | $279.0K | $146.0K | $247.0K | $249.0K | $224.0K | $65.0K | ||||||||||||
| Stock Issued During Period Value Stock Options Vested Of Restricted Stock Units And Exercised | $1.9M | -$55.0K | -$57.0K | -$169.0K | -$183.0K | -$340.0K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.